Clinical Development

Levamisole, An Orphan Drug for the Treatment of Nephrotic Syndrome
On 28 October 2005, orphan designation (EU/3/05/324) was granted by the European Commission to ACE Pharmaceuticals BV, The Netherlands,...
Download

Clinical Development White Papers

Levamisole, An Orphan Drug for the Treatment of Nephrotic Syndrome »10 Aug 06 »Submitted by
ACE Pharmaceuticals
client logon
Home
Industry Projects
Products & Services
Company A-Z
White Papers
Jobs & Careers
Press Releases
Advertise With Us
Events & Exhibitions
Newsletter
New On This Site
About Us
Atom FeedRSS Feed
What is RSS?